Hospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2024

  1. Exploring the role of ribosomal RNA modifications in cancer

    Current Opinion in Genetics and Development, Vol. 86

  2. Global and single-nucleotide resolution detection of 7-methylguanosine in RNA

    RNA Biology, Vol. 21, Núm. 1, pp. 1-18

  3. The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues

    NAR Cancer, Vol. 6, Núm. 1

2023

  1. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  2. N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer

    Oncogene, Vol. 42, Núm. 43, pp. 3169-3181

2022

  1. Epigenetic and Epitranscriptomic Control in Prostate Cancer

    Genes, Vol. 13, Núm. 2

2021

  1. A therapy PUSh for GBM

    Nature Cancer, Vol. 2, Núm. 9, pp. 876-878

  2. The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities

    Molecular Cancer, Vol. 20, Núm. 1

2020

  1. Glia Crosstalk in Neuroinflammatory Diseases

    Frontiers in Cellular Neuroscience, Vol. 14

2014

  1. Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting dna damage response

    Oncotarget, Vol. 5, Núm. 7, pp. 1770-1778

2013

  1. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression

    Cell Death and Disease, Vol. 4, Núm. 2

2012

  1. VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling

    Cellular and Molecular Life Sciences, Vol. 69, Núm. 22, pp. 3881-3893